Pratik S Velangi1, Christopher Choo2, Ko-Hsuan A Chen1, Felipe Kazmirczak1, Prabhjot S Nijjar1, Afshin Farzaneh-Far3,4, Osama Okasha1, Mehmet Akçakaya5, Jonathan W Weinsaft6, Chetan Shenoy1. 1. Cardiovascular Division, Department of Medicine (P.S.V., K.-H.A.C., F.K., P.S.N., O.O., C.S.), University of Minnesota Medical School, Minneapolis, MN. 2. Department of Medicine (C.C.), University of Minnesota Medical School, Minneapolis, MN. 3. Section of Cardiology, Department of Medicine, University of Illinois at Chicago, IL (A.F.-F.). 4. Division of Cardiology, Department of Medicine, Duke University, Durham, NC (A.F.-F.). 5. Department of Electrical and Computer Engineering, Center for Magnetic Resonance Research, University of Minnesota, Minneapolis, MN (M.A.). 6. Greenberg Cardiology Division, Department of Medicine, Weill Cornell Medical College, New York, NY (J.W.W.).
Abstract
BACKGROUND: Late gadolinium enhancement (LGE) cardiovascular magnetic resonance (CMR) imaging is more sensitive than echocardiography for the detection of intracardiac thrombus because of its unique ability to identify thrombus based on tissue characteristics related to avascularity. The long-term prognostic significance of left ventricular (LV) thrombus detected by LGE CMR is unknown. METHODS: We performed a matched cohort study of consecutive adult patients with LV thrombus detected by LGE CMR who were matched on the date of CMR, age, and LV ejection fraction to up to 3 patients without LV thrombus. We investigated the long-term incidence of a composite of embolic events: stroke, transient ischemic attack, or extracranial systemic arterial embolism. We also compared outcomes among patients with LV thrombus detected by LGE CMR stratified by whether the LV thrombus was also detected by echocardiography or not. RESULTS: Of 157 LV thrombus patients, 155 were matched to 400 non-LV thrombus patients. During a median follow-up of 3.3 years, the cumulative incidence of embolism was significantly higher in LV thrombus patients compared with the matched non-LV thrombus patients (P<0.001), with annualized rates of 3.7% and 0.8% for LV thrombus and matched non-LV thrombus patients, respectively. LV thrombus was the only independent predictor of the composite embolic end point (hazard ratio, 3.99 [95% CI, 1.54-10.35]; P=0.004). The cumulative incidence of embolism was not different in patients with LV thrombus that was also detected by echocardiography versus patients with LV thrombus not detected by echocardiography (P=0.25). CONCLUSIONS: Despite contemporary antithrombotic treatment, LV thrombus detected by LGE CMR is associated with a 4-fold higher long-term incidence of embolism compared with matched non-LV thrombus patients. LV thrombus detected by LGE CMR but not by echocardiography is associated with a similar risk of embolism as that detected by both LGE CMR and echocardiography.
BACKGROUND: Late gadolinium enhancement (LGE) cardiovascular magnetic resonance (CMR) imaging is more sensitive than echocardiography for the detection of intracardiac thrombus because of its unique ability to identify thrombus based on tissue characteristics related to avascularity. The long-term prognostic significance of left ventricular (LV) thrombus detected by LGE CMR is unknown. METHODS: We performed a matched cohort study of consecutive adult patients with LV thrombus detected by LGE CMR who were matched on the date of CMR, age, and LV ejection fraction to up to 3 patients without LV thrombus. We investigated the long-term incidence of a composite of embolic events: stroke, transient ischemic attack, or extracranial systemic arterial embolism. We also compared outcomes among patients with LV thrombus detected by LGE CMR stratified by whether the LV thrombus was also detected by echocardiography or not. RESULTS: Of 157 LV thrombuspatients, 155 were matched to 400 non-LV thrombuspatients. During a median follow-up of 3.3 years, the cumulative incidence of embolism was significantly higher in LV thrombuspatients compared with the matched non-LV thrombuspatients (P<0.001), with annualized rates of 3.7% and 0.8% for LV thrombus and matched non-LV thrombuspatients, respectively. LV thrombus was the only independent predictor of the composite embolic end point (hazard ratio, 3.99 [95% CI, 1.54-10.35]; P=0.004). The cumulative incidence of embolism was not different in patients with LV thrombus that was also detected by echocardiography versus patients with LV thrombus not detected by echocardiography (P=0.25). CONCLUSIONS: Despite contemporary antithrombotic treatment, LV thrombus detected by LGE CMR is associated with a 4-fold higher long-term incidence of embolism compared with matched non-LV thrombuspatients. LV thrombus detected by LGE CMR but not by echocardiography is associated with a similar risk of embolism as that detected by both LGE CMR and echocardiography.
Entities:
Keywords:
adult; echocardiography; embolism; humans; magnetic resonance imaging; prognosis; thrombosis
Authors: Luca Bettari; Mona Fiuzat; Richard Becker; G Michael Felker; Marco Metra; Christopher M O'Connor Journal: Circ Heart Fail Date: 2011-05 Impact factor: 8.790
Authors: Carol Mitchell; Peter S Rahko; Lori A Blauwet; Barry Canaday; Joshua A Finstuen; Michael C Foster; Kenneth Horton; Kofo O Ogunyankin; Richard A Palma; Eric J Velazquez Journal: J Am Soc Echocardiogr Date: 2018-10-01 Impact factor: 5.251
Authors: Gregory Y H Lip; Piotr Ponikowski; Felicita Andreotti; Stefan D Anker; Gerasimos Filippatos; Shunichi Homma; Joao Morais; Patrick Pullicino; Lars H Rasmussen; Francisco Marin; Deirdre A Lane Journal: Eur J Heart Fail Date: 2012-05-19 Impact factor: 15.534
Authors: Alexander E Merkler; Javid Alakbarli; Gino Gialdini; Babak B Navi; Santosh B Murthy; Parag Goyal; Jiwon Kim; Richard B Devereux; Monika M Safford; Costantino Iadecola; Hooman Kamel; Jonathan W Weinsaft Journal: J Stroke Cerebrovasc Dis Date: 2019-01-10 Impact factor: 2.136
Authors: Jonathan W Weinsaft; Raymond J Kim; Michael Ross; Daniel Krauser; Shant Manoushagian; Troy M LaBounty; Matthew D Cham; James K Min; Kirsten Healy; Yi Wang; Michele Parker; Mary J Roman; Richard B Devereux Journal: JACC Cardiovasc Imaging Date: 2009-08
Authors: Danai Kitkungvan; Faisal Nabi; Mohamad G Ghosn; Amish S Dave; Miguel Quinones; William A Zoghbi; Miguel Valderrabano; Dipan J Shah Journal: JACC Cardiovasc Imaging Date: 2016-05-25
Authors: Hans Huang; Prabhjot S Nijjar; Jeffrey R Misialek; Anne Blaes; Nicholas P Derrico; Felipe Kazmirczak; Igor Klem; Afshin Farzaneh-Far; Chetan Shenoy Journal: J Cardiovasc Magn Reson Date: 2017-03-24 Impact factor: 5.364
Authors: Chetan Shenoy; John D Grizzard; Dipan J Shah; Mahwash Kassi; Michael J Reardon; Marianna Zagurovskaya; Han W Kim; Michele A Parker; Raymond J Kim Journal: Eur Heart J Date: 2021-12-28 Impact factor: 35.855
Authors: Pratik S Velangi; Ko-Hsuan Amy Chen; Felipe Kazmirczak; Osama Okasha; Lisa von Wald; Henri Roukoz; Afshin Farzaneh-Far; Jeremy Markowitz; Prabhjot S Nijjar; Maneesh Bhargava; David Perlman; Mehmet Akçakaya; Chetan Shenoy Journal: JACC Cardiovasc Imaging Date: 2020-01-15